These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 8678954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
    Sugino K, Mimura T, Toshima K, Iwabuchi H, Kitamura Y, Kawano M, Ozaki O, Ito K.
    J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
    [Abstract] [Full Text] [Related]

  • 4. Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K, Mimura T, Ozaki O, Kure Y, Iwasaki H, Wada N, Matsumoto A, Ito K.
    World J Surg; 1995 Mar; 19(4):648-52. PubMed ID: 7676715
    [Abstract] [Full Text] [Related]

  • 5. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M.
    World J Surg; 1992 Mar; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, Matsumoto A, Ito K.
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [Abstract] [Full Text] [Related]

  • 9. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
    Lin YS, Lin JD, Hsu CC, Yu MC.
    J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
    [Abstract] [Full Text] [Related]

  • 10. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
    Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A.
    Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
    [Abstract] [Full Text] [Related]

  • 11. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
    Nonchev BI, Terzieva DD, Dimov RS, Mateva NG, Tsvetkova TZ, Dimitrakov DY.
    Folia Med (Plovdiv); 2005 Dec; 47(3-4):40-5. PubMed ID: 16761393
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK, Miller CC, Miltenburg DM.
    J Surg Res; 2000 May 15; 90(2):161-5. PubMed ID: 10792958
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
    Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, Pirola I, De Martino E, Rosei EA.
    Endocr J; 2007 Dec 15; 54(5):713-20. PubMed ID: 17675761
    [Abstract] [Full Text] [Related]

  • 18. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Dec 15; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 19. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE, Basedow Study Group.
    Thyroid; 2005 Sep 15; 15(9):1047-54. PubMed ID: 16187913
    [Abstract] [Full Text] [Related]

  • 20. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
    Smith J, Brown RS.
    Thyroid; 2007 Nov 15; 17(11):1103-7. PubMed ID: 17822376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.